New Clinical Approaches to Endocrine Therapy

New Clinical Approaches to Endocrine Therapy

A discussion with Dr. Vijay Paryani and Kassiane Saieed from Duke:

  • Guideline driven approaches for predicting which patients are likely to benefit from endocrine therapy beyond 5 years
  • Set clear endocrine therapy expectations from the beginning* and support
    endocrine therapy adherence
  • How to integrate current and new applications* of genomic testing

*Not currently available to order

The features and results of the Breast Cancer Index Test, to the extent they differ from the information found on the BreastCancerIndex.com website, including, but not limited to, the features concerning adjuvant endocrine therapy and ovarian function suppression: (i) are not currently available for clinical use; (ii) will be made available only after all required internal validations and regulatory requirements have been met; and (iii) is being provided herein for informational purposes only, and shall not be deemed to be an offer of availability.

Vijay Paryani, MD and Kassiane Saieed, DNP, AGNP-C are consultants of Biotheranostics, Inc., A Hologic Company. Statements reflect the speakers’ own personal views and interpretations.